How to Buy Cencora Stock
Cencora Inc
Cencora is a medical distribution company located in Pennsylvania, United States, which is part of the Healthcare sector, and is traded under the ticker COR on the NYSE exchange.
Cencora stock last closed at $237.95, up 0.11% from the previous day, and has increased 41.88% in one year. It has overperformed other stocks in the Medical Distribution industry by 0.08 percentage points. Cencora stock is currently +45.65% from its 52-week low of $163.37, and -3.57% from its 52-week high of $246.75.
There are currently 199.48M shares of COR outstanding. The market cap of COR is $47.47B. In the past 24 hours, 920,108 COR shares were traded.
How to Buy Cencora Stock
Wondering how to invest in Cencora stock? Here's how.
- Decide where to buy Cencora stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Cencora stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your payment method and add your details.
- Evaluate Cencora stock: The Cencora ticker symbol is COR. Is Cencora stock a good investment? Should you buy shares of COR? How do COR's underlying business fundamentals look? Do top analysts think Cencora is a good buy? Why has COR's stock price moved recently? (Hint: Our stock market analysis website can help you understand if COR is a good stock to buy).
- Make your COR buy order: Decide if you will purchase COR shares at the current market price or use a limit order to purchase COR stock at a specific price.
- Keep an eye on your COR investment: Create a watchlist to the latest updates on your new investment in Cencora stock.
Step 1: Decide where to buy Cencora stock
You need a brokerage account to access the NYSE market and buy COR shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Energy, New York to Shanghai — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal info so you are able to invest in COR today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on the highest rated app to buy and sell stocks, you can securely and quickly fund your account:
Watch the video below if you need help depositing funds into your brokerage account.
Step 4: Evaluate Cencora stock
After you have figured out the best place to buy Cencora stock, it's absolutely critical to evaluate their stock before you buy, so you can comprehend the risk as well as the upside.
Cencora Metrics
COR Due Diligence Checks
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on COR's stock page.
What is the fair value of COR stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge COR's true value.
Using relative valuations measures:
- COR may be undervalued based on its P/E ratio of 25.64x, relative to Medical Distribution industry P/E ratio of 26.05x
- COR may be undervalued based on its P/B ratio of 52.06x, relative to Medical Distribution industry P/B ratio of 146.51x
- COR may be undervalued based on its PEG ratio of 0.95x
You can access more valuation research on COR's stock here.
COR Financial Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the COR balance sheet.
- COR's operating cash flow of $4.09B allows it to safely service it's debt of $4.78B.
- COR earnings of $2.58B is not enough to cover its interest payments.
Failed Financial Due Diligence Checks:
- COR has a relatively high debt to equity ratio of 69.79.
- There are more short-term liabilities than short-term assets on the COR balance sheet.
- COR profit margin of X% has stayed the same in the past year.
- Total COR debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy COR stock
Out of 4 Equities analysts who monitor COR, the consensus analyst rating on Cencora is a Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Cencora stock forecast page.
Metrics for Advanced COR Traders
How are COR Revenues/Earnings doing?
Last year, COR earnings were $1.87B. Over the past five year, COR's earnings have increased by 10.95% per year. This was slower than the Medical Distribution industry average of 17.43%.
Last year, COR revenue was $271.58B. During the last five year, COR's revenue has grown by 9.46% per year. This was faster than the Medical Distribution industry average of 7.96%.
You can research COR's earnings and revenue performance here.
Who is buying/selling COR?
Over the past 12 months, insiders at COR have sold more shares than they have bought.
Steven H. Collis, Chairman President CEO of COR, was the latest COR insider to sell. They sold $2,553,859.92 worth of COR stock on Apr 16, 2024.
Get more info about who owns COR stock here.
Can I get consistent income from COR stock?
Cencora pays a dividend of 0.84%, compared to the Medical Distribution industry's average dividend yield of 1.8%. If you owned $1,000 worth of COR stock, you would have received $8.36 in the past year.
Cencora dividend payments have consistently grown over the past decade and have remained stable.
Find more analysis about Cencora dividend yield and history here.
What do other investors have to say about COR?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your COR buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you require more help with investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your COR investment
Now that you own some COR stock, you'll want to stay up-to-date on your company.
Create a watchlist to get notified of the latest news about your COR stock.
COR Feed
How to Buy Stock in Cencora
To summarize, here are the 6 steps you need to take to buy Cencora stock right now:
- Decide where to buy Cencora stock
- Sign up for your brokerage account
- Fund your investment account
- Evaluate Cencora stock
- Make your COR buy order
- Keep an eye on your COR investment
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to watch your investment in Cencora, create a watchlist today.
Other Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.